Anti-depressant medication use and C-reactive protein: results from two population-based studies
about
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profileInflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant usersDepressive symptoms and the risk of ischemic stroke in the elderly--influence of age and sex.Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey.Marked mydriasis and neuritis nervi optici associated with galactorrhea following citalopram treatment: a case report and discussionReduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder.Association of depressive disorders, depression characteristics and antidepressant medication with inflammation.Taking the Perspective that a Depressive State Reflects Inflammation: Implications for the Use of AntidepressantsPostsurgical Depressive Symptoms and Proinflammatory Cytokine Elevations in Women Undergoing Primary Treatment for Breast Cancer.Elevated maternal C-reactive protein and autism in a national birth cohortDoes CRP predict outcome in bipolar disorder in regular outpatient care?Weight and metabolic effects of dietary weight loss and exercise interventions in postmenopausal antidepressant medication users and non-users: a randomized controlled trial.Cytokine production capacity in depression and anxiety.Inflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease.Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies.C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.Severity of depressive symptoms as a predictor of mortality: the English longitudinal study of ageing.
P2860
Q21245293-43413380-DD4F-4F8E-B2B4-A2E83E8B21B8Q33620656-350EB7EA-2DC7-4D88-9DE9-E6740326498CQ34505937-522056A1-84BC-4275-8F2F-346DDDB99A69Q34571252-ADFF052C-60C5-4760-97CB-74D6B5366C03Q35176686-1319FAB9-4CAC-408A-BC71-154BCB3FE565Q35554351-9A8F9B5F-AC87-45F2-A440-A8929689A796Q35844355-69A476F7-BFF7-4D3A-B4D9-D436A74FE461Q36171115-E9996CBE-E28F-41EF-8922-EF9E4B43C2D1Q36418520-9C31B32B-E4C4-460B-B23D-866AA2F66F93Q36787986-D740EF2E-B7D6-4F70-8E0E-750962B046F0Q37104437-5A37D085-B611-4D61-86BB-658B1B4FA6BBQ37238741-801D385F-5CC7-4A04-90E2-0AF55AEF394CQ37349852-1B590F0C-15F4-427E-A995-A7CE2D84CD72Q39004263-B44D1C79-F900-4E45-80AD-AC919D746EC4Q39077689-796C2075-07A4-448A-BFFC-3F5CC1AD36DFQ48063579-DBA503C1-FFBE-4AD4-9956-DDE5F3306BD4Q48083971-41D2B5F3-6CE0-4F8A-887A-409A66C872E1
P2860
Anti-depressant medication use and C-reactive protein: results from two population-based studies
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Anti-depressant medication use ...... m two population-based studies
@ast
Anti-depressant medication use ...... m two population-based studies
@en
Anti-depressant medication use ...... m two population-based studies
@nl
type
label
Anti-depressant medication use ...... m two population-based studies
@ast
Anti-depressant medication use ...... m two population-based studies
@en
Anti-depressant medication use ...... m two population-based studies
@nl
prefLabel
Anti-depressant medication use ...... m two population-based studies
@ast
Anti-depressant medication use ...... m two population-based studies
@en
Anti-depressant medication use ...... m two population-based studies
@nl
P2860
P50
P1476
Anti-depressant medication use ...... m two population-based studies
@en
P2093
P2860
P304
P356
10.1016/J.BBI.2010.09.013
P577
2010-09-21T00:00:00Z